Retractable Technologies (RVP) Cost of Revenue (2010 - 2026)
Retractable Technologies' (RVP) quarterly Cost of Revenue came in at $7.0 million in Q2 2026, down 33.57% on a YoY basis from $10.6 million in Q2 2025, and down 12.55% quarter-over-quarter from $8.0 million in Q1 2026.
Analysis
Retractable Technologies (RVP) Cost of Revenue (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Cost of Revenue for 17 consecutive years, with $7.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cost of Revenue fell 33.57% year-over-year to $7.0 million; the trailing twelve-month figure through Jun 2026 stood at $34.4 million (down 15.66% YoY), and the FY2025 full-year result was $38.2 million, up 12.15% from the prior year.
- Cost of Revenue declined to $7.0 million in Q2 2026 per RVP's latest filing, from $8.0 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $29.2 million in Q1 2022 and bottomed at $5.7 million in Q1 2024.
- Historically, Cost of Revenue has averaged $10.5 million across 5 years, with a median of $8.4 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Cost of Revenue slumped 72.13% in 2023, then jumped 72.28% in 2024.
- Over 5 years, Cost of Revenue stood at $8.4 million in 2022, then surged by 52.2% to $12.7 million in 2023, then slipped by 9.26% to $11.6 million in 2024, then dropped by 5.18% to $11.0 million in 2025, then tumbled by 36.1% to $7.0 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $7.0 million, $8.0 million, and $11.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 2.67 Bn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 5.47 Bn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 543.10 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 1.93 Bn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 250.13 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 36.03 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 14.54 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 7.01 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.01 Mn |
| Mar 31, 2026 | 8.02 Mn |
| Dec 31, 2025 | 10.97 Mn |
| Sep 30, 2025 | 8.40 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Mar 31, 2025 | 8.30 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Sep 30, 2024 | 10.36 Mn |
| Jun 30, 2024 | 6.45 Mn |
| Mar 31, 2024 | 5.70 Mn |
| Dec 31, 2023 | 12.75 Mn |
| Sep 30, 2023 | 6.01 Mn |
| Jun 30, 2023 | 7.59 Mn |
| Mar 31, 2023 | 8.13 Mn |
| Dec 31, 2022 | 8.38 Mn |
| Sep 30, 2022 | 18.32 Mn |
| Jun 30, 2022 | 10.69 Mn |
| Mar 31, 2022 | 29.17 Mn |
| Dec 31, 2021 | 25.14 Mn |
| Sep 30, 2021 | 22.96 Mn |